Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
Scientifically acceptable, well-documented study. The conduct was similar to OECD 403 but no particle size analysis was undertaken. However, within a further similar acute inhalation study performed by the same author (see BASF83/59), a particle size analysis was conducted, which revealed that 100% of the test substance applied as liquid aerosol reached the lung alveoli.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1994
Report date:
1994

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
Principles of method if other than guideline:
Ten male and ten female Sprague-Dawley rats per dose group were exposed to different concentrations of test material as liquid aerosol; the animals were subjected to a head-nose exposure for 4 hours. The exposure period was followed by an observation period of 14 days. During and after exposure, mortality and clinical signs of toxicity were recorded at regular time intervals. The body weight was determined prior test initiation and thereafter, on day 7 and day 14 post-exposure. Rats that died during the experiment were subjected to necropsy; those which survived were sacrificed at the end of the experiment and were also subjected to necropsy. An untreated rat collective served as control. The determination of the LC50 values was based on the Probit Analysis.
GLP compliance:
no
Remarks:
; GLP was not compulsory at the time the study was performed
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Glutaral
EC Number:
203-856-5
EC Name:
Glutaral
Cas Number:
111-30-8
Molecular formula:
C5H8O2
IUPAC Name:
glutaraldehyde
Test material form:
liquid
Specific details on test material used for the study:
- Name of test material (as cited in study report): Glutaraldehyde approx. 50% solution, poor in methanol
- Physical state: liquid
- Analytical purity: 50%
- Lot/batch No.: the test substance No. was 80/265
- Stability under test conditions: approx. 12 months

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
- Source: Willi Gassner, Sulzfeld, Germany (animal breeder)
- Age at study initiation: 8 weeks
- Mean body weight of the males at study initiation: 298 +/- 35 g
- Mean body weight of the females at study initiation: 224 +/- 28 g
- Housing: animals were housed in groups of five in wire cages of Becker, type D III, without bedding.
- Diet (e.g. ad libitum): SSNIFF R complete diet for rats and mice, supplied by SSNIFF-Versuchstierdiäten GmbH (Soest, FRG), ad libitum
- Water (e.g. ad libitum): Tap water ad libitum
- Temperature (°C): 22 +/- 2 °C
- Humidity (%): 55 +/- 5 %
- Photoperiod (hrs dark / hrs light): 12 h/ 12 h

Administration / exposure

Route of administration:
inhalation: aerosol
Type of inhalation exposure:
nose/head only
Vehicle:
other: The test substance was offered to the animals as a liquid aerosol/air mixture
Details on inhalation exposure:
AEROSOL GENERATION, EXPOSURE SYSTEM AND PROCEDURE
- Constant amounts of test substance were supplied to a two-component atomizer by means of a metering pump;
- By means of compressed air (1.8 bar) a mixture of test substance and air (liquid aerosol) was generated, which was passed into the inhalation system;
- The inhalation system was a head-nose inhalation system INA 20, BASF AG, V ca. 55 l;
- By means of the exhaust air system the pressure ratios in the inhalation system were adjusted in such a way that the amount of fresh air was about 10% higher (excess pressure) . This ensured that the mixture of test substance and air was not diluted by laboratory air in the breathing zones of the animals.

AIR SAMPLING FOR ANALYSIS OF TEST MATERIAL CONCENTRATIONS, METHOD FOR ANALYTICAL VERIFICATION
- A sampling apparatus consisted of 2 impingers connected in series and a downstream fritted glass flask was used;
- The sampling sites were Inmediately adjacent to the animal noses;
- One sample per concentration group was collected every hour;
_ The sampling flow was 1.25 m/s, and the sample amount reached up to 50 litres;
- The analytical measurement of the test material concentrations in the collected samples was based on gas-chromatography.

PARTICLE SIZE ANALYSIS:
No particle size analysis was undertaken within the present study. However, within a further similar acute inhalation study performed by the same author (see BASF83/59), a particle size analysis was conducted, which revealed that 100% of the test substance applied as liquid aerosol reached the lung alveoli.
Analytical verification of test atmosphere concentrations:
yes
Remarks:
For details, see above
Duration of exposure:
4 h
Concentrations:
Nominal: 0.23, 0.41, 0.53, 0.68 and 0.9 mg/l
Measured: 0.10, 0.18, 0.28, 0.39 and 0.44 mg/l
No. of animals per sex per dose:
10 animals/sex/group
Control animals:
yes
Details on study design:
- The animals were subjected to a head-nose exposure for 4 hours; this was followed by an observation period of 14 days;
- The rats were observed during exposure and over a period of 14 days for mortality (daily) and clinical signs of toxicity (each workday
- Body weights were recorded at test initiation, after 7 days and at the end of the observation period;
- Animals that died during the observation period were subjected to necropsy and gross pathological examination,
- Animals that survived were sacrificed at the end of the exposure period by means of CO2 for necropsy and gross pathology.
- An untreated rat collective served as control.
Statistics:
The determination of the LC50 value was based on Probit Analysis according to Finney DJ, Cambridge University Press, 3rd edition, 1971.

Results and discussion

Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
LC50
Effect level:
0.28 - 0.39 mg/L air (analytical)
Exp. duration:
4 h
Sex:
male
Dose descriptor:
LC50
Effect level:
0.35 mg/L air (analytical)
95% CL:
0.3 - 0.39
Exp. duration:
4 h
Sex:
female
Dose descriptor:
LC50
Effect level:
0.28 mg/L air (analytical)
95% CL:
0.22 - 0.29
Exp. duration:
4 h
Mortality:
- in the control group, all animals survived;
- in the 0.18 mg/l air group, mortality was 4/20, i.e. 20%;
- in the 0.28 mg/l air group, mortality was 4/20, i.e. 20%;
- in the 0.39 mg/ l air group, mortality was 14/20, i.e. 70%;
- in the 0.44 mg/l air group, mortality was 19/20, i.e. 95%.
Clinical signs:
other: During the exposure period vigorous attempts to escape, wiping of the snout, lid closure, and aqueous or red discharge from eyes and noses were observed. During the post-exposure period whooping or gasping respiration with rasping sounds during inspiratio
Body weight:
After 7 days, the body weights of the treated males were clearly impaired compared to controls; After 14 days this impairment still was observed in the 0.28 and the 0.39 mg/l groups. For the females, the body weight in the 0.39 mg/l group was impaired during the whole observation period; the body weight of the 0.28 mg/l group only was affected after 7 days.
Gross pathology:
- Necropsy of the animals that died during the experiment revealed acute congestion, pronounced emphysema of the lungs as well as edematization and infarctoid hyperemia.
- Necropsy of the surviving animals, which were sacrificed at the end of the observation period, showed no pathological abnormalities.

Any other information on results incl. tables

Details on mortality:

Applied Test Con. (mg/l)

Mortality (males)

Mortality (females)

Mortality (both sex)

0.10

0/10

0/10

0/20 (0%)

0.18

1/10 (d14)*

3/10 (d1-d2)

4/20 (20%)

0.28

1/10 (d1)

3/10 (d2-d7)

4/20 (20%)

0.39

7/10 (4h-d2)

7/10 (4h-d2)

14/20 (70%)

0.44

9/10 (4h-d1)

10/10 (4h-d14)

19/20 (95%)

*, Time of death after dosing (h, hours; d, days)

Details on mean body weights/sex/group:

Applied Test Con. (mg/l)

 Initially

After 7 days**

After 14 days**

Males

Females

Males

Females

Males

Females

0*

307 g

230 g

340 g

240 g

367 g

249 g

0.10

289 g

228 g

324 g

238 g

376 g

252 g

0.18

304 g

224 g

319 g

238 g

360 g

246 g

0.28

305 g

222 g

320 g

228 g

343 g

240 g

0.39

287 g

211 g

316 g

211 g

321 g

208 g

0.44

304 g

232 g

285 g

168 g

334 g

-***

*, Control group of 90 animals/sex.

**, The mean body weight refers to the surviving rats.

***, No survivors.

Applicant's summary and conclusion

Interpretation of results:
Category 2 based on GHS criteria
Conclusions:
- Acute inhalation toxicity (rat, 4 h exposure): 0.28 < LC50 < 0.39 mg/L air (50% glutaraldehyde)